论文部分内容阅读
↑有研究者宣布,一种尚处于实验阶段的,新的血液稀释剂prasugrel,其对于因动脉栓塞所致心脏问题的防治作用优于同类畅销药Plavix。图为发表该声明的研究者,医学博士Steven。
↑ Researchers have announced that a new experimental blood-thinning prasugrel is superior to Plavix, the best-selling drug for preventing and treating heart problems caused by arterial embolism. The picture shows the author of the statement, MD Steven.